[Federal Register: April 17, 1998 (Volume 63, Number 74)]
[Notices]               
[Page 19245]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr17ap98-28]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army

 
Prospective Grant of Exclusive Patent License

AGENCY: Headquarters, U.S. Army Materiel Command (AMC), DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the provisions of 15 U.S.C. 209(c)(1) and 
37 CFR Part 404.7(a)(1)(i), AMC hereby gives notice that it is 
contemplating the grant of an exclusive license in the United States to 
practice the inventions embodied in U.S. Patent Application Serial No. 
08/796,772, filed February 6, 1997, entitled ``Detection of Multiple 
Antigens and Antibodies,'' and U.S. Patent Application (no number 
assigned), filed February 18, 1998, entitled ``Method and Apparatus for 
Detection of Multiple Nucleic Acid Sequences and Multiple Antigens'' to 
Epitope, Inc., having a place of business in Beaverton, Oregon.

FOR FURTHER INFORMATION CONTACT: Mr. Bill Medsger, Headquarters, U.S. 
Army Materiel Command, ATTN: AMCCC-IP, 5001 Eisenhower Ave., 
Alexandria, VA 22333-0001. Phone: (703) 617-2556; FAX: (703) 617-2556.

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be 
royalty bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted, unless within sixty days from the date of this published 
Notice, AMC receives written evidence and argument which establishes 
that the grant of the license would not be consistent with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 98-10248 Filed 4-16-98; 8:45 am]
BILLING CODE 3710-08-M